Marathon Asset Management

Marathon Asset Management welcomed Alex Howell as a senior managing director and head of European Alternative Credit. He spent over 10 years at Blackstone Credit and GSO Capital.

Private equity, real estate, credit and venture capital firms closed in on more than $42 billion in assets in March 2023, compared with $26 billion in the year-ago period.

Curt Lueker joined Marathon Asset Management as managing director with an aim of leading the $20 billion credit-focused firm’s sponsor’s coverage and direct lending business. Lueker brings with him bank lending experience after being active in building middle market leveraged ...

New York-based firms Marathon Asset Management and Deerpath Capital Management have closed on over $900 million in new collateralized loan obligation offerings in recent weeks as demand for collateralized products picks up alongside interest rates moves. Earlier this month, Marathon ...

The $124 billion Minnesota State Board of Investment approved a new target range for private markets of between 20% and 32% of overall assets.

Marathon Asset Management closed its latest collateralized loan obligation (CLO) at $400 million -- the first new CLO executed on Marathon’s global performing credit platform this year. The Bryant Park Funding 2023-19 Ltd. is the first CLO under the $20 ...

Divided by asset class, Alternatives Watch tracked about $19.3 billion in private market deals announced in the week ending Dec. 16.

Marathon Asset Management hired Karen Lau in credit as managing director and senior portfolio manager within the Corporate Credit group as its CLO strategy surpasses $5 billion in assets.

Marathon Asset Management, the New York-based global credit manager with over $23 billion in assets under management, announced this week that its chief legal officer and chief compliance officer, Christine Chartouni, has been promoted to partner. The partnership’s chief investment ...

Marathon Asset Management signed a deal to acquire Kaléo for $310 million in cash as the firm boosts its healthcare-oriented investments. Richmond, Virginia-based Kaléo is a privately held pharmaceutical company that serves patients at risk for anaphylaxis and other serious ...